The Platelet Antibodies, Indirect (IgG, IgM, IgA) panel, featuring the Platelet Ab, Indirect (IgA) test, is a significant diagnostic asset in the realms of hematology and immunology, particularly for assessing conditions like thrombocytopenia (low platelet count) and platelet dysfunction. The Platelet Ab, Indirect (IgA) component specifically measures the presence of immunoglobulin A (IgA) antibodies that target platelets. These antibodies are crucial in diagnosing autoimmune conditions where the immune system mistakenly attacks and destroys its own platelets, leading to thrombocytopenia. The presence of IgA platelet antibodies can indicate Immune Thrombocytopenia (ITP), where these antibodies mark platelets for destruction. Additionally, this test is valuable in identifying drug-induced thrombocytopenia, where certain medications stimulate the production of platelet-specific antibodies, and in rare conditions like post-transfusion purpura, following a blood transfusion. The Platelet Ab, Indirect (IgA) test in this comprehensive panel is pivotal for accurate diagnosis, ongoing monitoring, and effective management of these disorders. Its ability to sensitively detect IgA antibodies against platelets is key in guiding treatment strategies, which might include immunosuppressive therapy or specific platelet transfusion management.
Platelet Ab, Indirect (IgA)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.